Maddi Hebebrand, MC, Associate Editor

The JAK1 inhibitor provided significant relief for 2 patients with refractory PN.

New research shows the 675-nm laser enhances skin texture and rejuvenation, making it a valuable tool for various dermatological conditions.

Arcutis' study of ARQ-255 aims to address the lack of FDA-approved topical treatments for alopecia areata, a condition affecting roughly 1 in 500 people.

The study stated that enhancing patient education and psychological support can improve rosacea management and quality of life.

Although clinicians showed similar antibiotic prescribing rates, the study highlights a need for better adherence to HS treatment guidelines across all specialties.

The review found that patients with PN are approximately 1.3 times more susceptible to depression and 1.9 times more likely to experience anxiety.

The phase 2 trial for EVO756, targeting mast cell-related CIndU, is now underway at 15 US study sites.

A recent study revealed a spectrum of photosensitivity in AD, with varying symptoms and sensitivities.

Recent studies found that PRP therapy leads to noticeable decreases in hair shedding and increases in hair thickness.

Researchers identified KLB and EIF3C as potential biomarkers for vitiligo and AA, offering new targets for early diagnosis and treatment.

Chronic hand eczema patients with high corticosteroid phobia are less likely to follow prescribed treatments, indicating a need for improved education.

A recent review highlighted how AI can be used to enhance diagnostic accuracy, consultations, treatment planning, and patient education.

Results from the study highlight that the therapy improves AD symptoms over time, with 71.9% of participants achieving substantial improvement.

The study found that after 4 weeks of using the action plan, AD severity decreased markedly, with many patients achieving mild AD status.

The findings support the idea that Botox can enhance emotional well-being and self-confidence, although it did not notably impact the quality of life.

A recent study found after 6 months, CGF therapy resulted in a sustained increase in terminal hair density without significant adverse events.

A recent study found prefilled pens with concealed needles showed promise in reducing injection-related anxiety and improving patient adherence.

A recent study confirmed that collagen peptides effectively counteract age-related skin issues such as reduced density and increased dryness.

Researchers identified mistrust, social stigma, and language barriers as major obstacles for ethnic minorities in skin research.

The National Psoriasis Foundation's new report provides an overview of the health impacts of psoriasis, revealing significant issues in care and outcomes.

The study found 95.8% of ocular AEs occurred in AD patients, while SA patients reported only 4.2% of these events.

The availability is notable as it introduces the first oral treatment option for young psoriasis patients.

Preliminary data suggests that the exosomes could effectively address common skin concerns, including firmness, photodamage, and fine lines.

Researchers stated the integration of wearable sensors with AI could potentially revolutionize care for patients with atopic dermatitis.

The study found that higher doses of BTX “significantly” improved facial erythema and patient quality of life compared to lower doses.

Although EBDs provided improvements over controls, they did not match the sebum reduction levels achieved by isotretinoin or hormonal therapies.

Despite high accuracy scores, the study found AI models often produce overly complex explanations, making them less effective for patient education.

The trial revealed that 40% of patients on izokibep achieved HiSCR75 by week 16, a notable improvement over the 20% on placebo.

Researchers suggested that itch control is key in reducing disease burden and improving life quality for patients with psoriasis and atopic dermatitis.

The study found 277 differentially expressed genes shared by RA and rosacea, opening up opportunities for treatment research.